BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND PAX7, PAX7B, 5081, ENSG00000009709, P23759, HUP1
218 results:

  • 1. Germline Genetic Testing and Survival Outcomes Among Children With Rhabdomyosarcoma: A Report From the Children's Oncology Group.
    Martin-Giacalone BA; Li H; Scheurer ME; Casey DL; Dugan-Perez S; Marquez-Do DA; Muzny D; Gibbs RA; Barkauskas DA; Hall D; Stewart DR; Schiffman JD; McEvoy MT; Khan J; Malkin D; Linardic CM; Crompton BD; Shern JF; Skapek SX; Venkatramani R; Hawkins DS; Sabo A; Plon SE; Lupo PJ
    JAMA Netw Open; 2024 Mar; 7(3):e244170. PubMed ID: 38546643
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The diagnostic utility of cytology specimen in a case of EWSR1::NFATC2 sarcoma.
    Takeda N; Makise N; Kageyama H; Takahashi T; Katoh H; Odaka A; Oikawa M; Sugiyama T; Kawana H; Araki A; Kinoshita H; Hagiwara Y; Kamoda H; Yonemoto T; Itami M
    Virchows Arch; 2024 Mar; 484(3):533-538. PubMed ID: 38483612
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Transforming Growth Factor Beta and Alveolar Rhabdomyosarcoma: A Challenge of Tumor Differentiation and Chemotherapy Response.
    Bhushan B; Iranpour R; Eshtiaghi A; da Silva Rosa SC; Lindsey BW; Gordon JW; Ghavami S
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38474036
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Inflammatory Rhabdomyoblastic Tumor: Clinicopathologic and Molecular Analysis of 13 Cases.
    Odate T; Satomi K; Kubo T; Matsushita Y; Ueno T; Kurose A; Shomori K; Nakai T; Watanabe R; Segawa K; Ohshika S; Miyake N; Kudo S; Shimoi T; Kobayashi E; Komiyama M; Yoshimoto S; Nakatani F; Kawai A; Yatabe Y; Kohsaka S; Ichimura K; Ichikawa H; Yoshida A
    Mod Pathol; 2024 Jan; 37(1):100359. PubMed ID: 37871654
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Registry SoTiSaR.
    Heinz AT; Schönstein A; Ebinger M; Fuchs J; Timmermann B; Seitz G; Vokuhl C; Münter M; Pajtler KW; Stegmaier S; von Kalle T; Kratz CP; Ljungman G; Juntti H; Klingebiel T; Koscielniak E; Sparber-Sauer M;
    Pediatr Blood Cancer; 2024 Jan; 71(1):e30707. PubMed ID: 37814424
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Biphenotypic Sinonasal Sarcoma with a Novel pax7::PPARGC1 Fusion: Expanding the Spectrum of Gene Fusions Beyond the PAX3 Gene.
    Bhele S; Chrisinger JSA; Farrell NF; Van Tine BA; Raptis CA; Chernock RD
    Head Neck Pathol; 2023 Sep; 17(3):826-831. PubMed ID: 37378830
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Extremity Rhabdomyosarcoma-An Integrated Clinicopathologic and Genomic Study to Improve Risk Stratification.
    de Traux de Wardin H; Xu B; Dermawan JK; Smith MH; Wolden SL; Antonescu CR; Wexler LH
    JCO Precis Oncol; 2023 Jun; 7(1):e2200705. PubMed ID: 37315267
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Expression of Ras signaling pathway proteins and developmental factors in peripheral nerve sheath tumors of patients with neurofibromatosis type 1.
    Hagel C; Nörnberg LKN; Friedrich RE
    Clin Neuropathol; 2023; 42(4):150-160. PubMed ID: 37226590
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Novel characteristics for immunophenotype, FISH pattern and molecular cytogenetics in synovial sarcoma.
    Zhong LL; Huang GX; Xian LY; Wei ZC; Tang ZP; Chen QY; Chen H; Tang F
    Sci Rep; 2023 May; 13(1):7954. PubMed ID: 37193761
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Diagnostic utility of FOXO1 immunohistochemistry for rhabdomyosarcoma classification.
    Rutland CD; Gedallovich J; Wang A; Zdravkovic S; Varma S; Hornick JL; Charville GW
    Histopathology; 2023 Jul; 83(1):49-56. PubMed ID: 36860202
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Alveolar rhabdomyosarcoma: novel surrogate markers associated with oncogenic translocation].
    Tarakanova AV; Sharlay AS; Konovalov DM
    Arkh Patol; 2023; 85(1):10-15. PubMed ID: 36785957
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Circulating Tumor DNA Is Prognostic in Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group.
    Abbou S; Klega K; Tsuji J; Tanhaemami M; Hall D; Barkauskas DA; Krailo MD; Cibulskis C; Nag A; Thorner AR; Pollock S; Imamovic-Tuco A; Shern JF; DuBois SG; Venkatramani R; Hawkins DS; Crompton BD
    J Clin Oncol; 2023 May; 41(13):2382-2393. PubMed ID: 36724417
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. PAX-FOXO1 fusion status in children and adolescents with alveolar rhabdomyosarcoma: Impact on clinical, pathological, and survival features.
    Raze T; Lapouble E; Lacour B; Guissou S; Defachelles AS; Gaspar N; Delattre O; Pierron G; Desandes E
    Pediatr Blood Cancer; 2023 Apr; 70(4):e30228. PubMed ID: 36722003
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Biphenotypic sinonasal sarcoma with PAX3::MAML3 fusion transforming into high-grade rhabdomyosarcoma: report of an emerging rare phenomenon.
    Meyer A; Klubíčková N; Mosaieby E; Grossmann P; Kalmykova A; Koshyk O; Michal M
    Virchows Arch; 2023 Apr; 482(4):777-782. PubMed ID: 36719455
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Ewing and Ewing-like sarcomas: A morphological guide through genetically-defined entities.
    Yoshida A
    Pathol Int; 2023 Jan; 73(1):12-26. PubMed ID: 36484765
    [TBL] [Abstract] [Full Text] [Related]  

  • 16.
    Aljerian K
    Fetal Pediatr Pathol; 2023 Jun; 42(3):385-393. PubMed ID: 36484735
    [No Abstract]    [Full Text] [Related]  

  • 17. Divergent transcriptional and transforming properties of PAX3-FOXO1 and pax7-FOXO1 paralogs.
    Manceau L; Richard Albert J; Lollini PL; Greenberg MVC; Gilardi-Hebenstreit P; Ribes V
    PLoS Genet; 2022 May; 18(5):e1009782. PubMed ID: 35604932
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Pulmonary "Inflammatory Leiomyosarcomas" Are Indolent Tumors With Diploid Genomes and No Convincing Rhabdomyoblastic Differentiation.
    Kao YC; Kuo CT; Kuo PY; Huang HY; Lu TP; Hsieh TH; Fletcher CDM; Lee JC
    Am J Surg Pathol; 2022 Mar; 46(3):424-433. PubMed ID: 35175969
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Does pax7 and NKX2.2 immunoreactivity in Ewing sarcoma have prognostic significance?
    Machado I; Charville GW; Yoshida A; Navarro S; Righi A; Gambarotti M; Scotlandi K; López-Guerrero JA; Llombart-Bosch A
    Virchows Arch; 2022 Apr; 480(4):909-917. PubMed ID: 34985580
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [Alveolar rhabdomyosarcoma: Two fusion-negative cases lacking PAX3-FOXO1 and pax7-FOXO1].
    Mestre-Alagarda C; Gómez-Mateo MC; Berenguer-Romero MD; Syonghyun NC; Nieto G; Navarro-Fos S
    Rev Esp Patol; 2022; 55(1):57-62. PubMed ID: 34980443
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 11.